| 000 | 00879 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250518034943.0 | ||
| 264 | 0 | _c20191007 | |
| 008 | 201910s 0 0 eng d | ||
| 022 | _a0392-856X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFasano, Serena | |
| 245 | 0 | 0 |
_aPresent and novel biologic drugs in primary Sjögren's syndrome. _h[electronic resource] |
| 260 |
_bClinical and experimental rheumatology _c |
||
| 300 |
_a167-174 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aB-Lymphocytes |
| 650 | 0 | 4 |
_aBiological Products _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 |
_aSjogren's Syndrome _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aXerostomia |
| 700 | 1 | _aIsenberg, David A | |
| 773 | 0 |
_tClinical and experimental rheumatology _gvol. 37 Suppl 118 _gno. 3 _gp. 167-174 |
|
| 999 |
_c29628683 _d29628683 |
||